Filter
5285
Filtered Results: 5285
Text search:
investigation
Featured
Recommendations
506
New Publications
1330
Language
Document type
No document type
2959
Guidelines
845
Studies & Reports
769
Manuals
249
Strategic & Response Plan
200
Fact sheets
99
Training Material
76
Situation Updates
50
Resource Platforms
12
Infographics
11
Online Courses
9
Brochures
5
Videos
1
Countries / Regions
India
270
Global
157
South Africa
117
Latin America and the Carribbean
112
Congo, Democratic Republic of
111
Western and Central Europe
99
Sierra Leone
97
Ethiopia
95
Kenya
94
Liberia
93
Uganda
86
Nigeria
77
Africa
74
Rwanda
62
Malawi
61
Nepal
60
Bangladesh
60
Myanmar / Burma
58
Senegal
57
Tanzania
57
Venezuela
56
Ghana
51
Syria
50
Brazil
48
Zambia
47
Colombia
45
Paraguay
41
Argentina
40
Guinea
39
South Sudan
39
West and Central Africa
38
Namibia
35
Ukraine
35
Eastern Europe
35
Burkina Faso
34
Philippines
33
Russia
33
Haiti
32
South–East Asia Region
32
Zimbabwe
30
Mozambique
30
East and Southern Africa
30
Peru
28
Lesotho
27
Middle East and North Africa
27
Germany
26
Indonesia
25
Botswana
24
Madagascar
23
Cameroon
22
Bolivia
22
Mali
21
Central African Republic
21
Cambodia
20
Yemen
19
Eswatini/ Swaziland
18
Chile
17
Pakistan
16
Asia
16
Eastern Europe and Central Asia
15
Benin
14
Afghanistan
13
Spain
13
Somalia
12
Ecuador
12
Angola
11
Côte d’Ivoire / Ivory Coast
10
USA
10
Jordan
10
Niger
9
Lebanon
9
Chad
9
El Salvador
9
Thailand
8
Western Pacific Region
8
Sudan
7
Togo
6
Iraq
6
Burundi
6
Vietnam
6
United Kingdom
6
Guinea-Bissau
5
Turkey
5
Honduras
5
Sri Lanka
5
France
5
China
4
Papua New Guinea
4
North Macedonia
4
Libya
4
Mexico
4
Albania
4
Laos
4
Timor Leste/ East Timor
4
Moldova
4
Portugal
4
Egypt
3
Gambia
3
Singapore
3
Guatemala
3
Bhutan
3
Palestine
3
Armenia
3
Tajikistan
3
Georgia
3
North America
3
Morocco
2
Dominican Republic
2
Serbia
2
Italy
2
Congo-Brazzaville
2
Canada
2
Estonia
2
Lithuania
2
Iran
2
Uruguay
2
Belarus
2
Israel
2
Bosnia and Herzegovina
2
Saudi Arabia
1
Malaysia
1
Switzerland
1
Croatia
1
Cuba
1
Greece
1
Nicaragua
1
Other region
1
Fiji
1
Poland
1
North Korea
1
Mongolia
1
Romania
1
Australia
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
2021
Clinical Guidelines
465
Public Health
230
Women & Child Health
226
Key Resources
190
Capacity Building
77
Pharmacy & Technologies
77
Toolboxes
COVID-19
615
Mental Health
423
TB
420
Rapid Response
292
HIV
285
Ebola
233
AMR
163
Planetary Health
148
Disability
134
NTDs
131
Conflict
115
Caregiver
112
Pharmacy
93
NCDs
87
Refugee
84
Zika
71
Cholera
53
Polio
46
Natural Hazards
45
Specific Hazards
39
Global Health Education
39
Health Financing Toolbox
26
Social Ethics
19
Health Financing
3
Typhoon
2
The Strategy aims to protect and improve the well-being
of society and of the individual, to protect and promote
public health, to offer a high level of security and well-being
for the general public and to increase health literacy. The
Strategy takes an evidence-based, integrated, balanced and
...
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
Parasites & Vectors volume 15, Article number: 389 (2022)
Dengue is one of the common arboviral infections and is a public health problem in South East Asia. The aim of this systematic review and meta-analysis was to evaluate the prevalence and distribution of dengue in SAARC (South Asian Associ...
Surveillance Report
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031.
The technical bri...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
The Arab region in the Middle East and North Africa (MENA) represents a substantial area of the terrestrial landmass encompassing several countries and ecosystems. This area is generally drier and warmer compared to the rest of the world and has extreme resource limitations that are highly vulnerabl...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
The MHPSS MSP is an easy-to-follow intersectoral package, which spells out the activities and actions that all humanitarian actors should put in place in all emergencies for an effective MHPSS response. It speaks to different actors at the global, regional, national, and local levels to plan, coordi...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
